lobbying_activities: 1690924

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1690924	ec3377a4-9715-42e9-a522-7e6d8e5c8d74	Q2	ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC)	1466	ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC)	2015	second_quarter	MED	AACC contacted House and Senate staff and legislators to express concerns about ongoing efforts to expand Food and Drug Administration oversight to laboratory developed tests. Currently LDTs are regulated by the Centers for Medicare and Medicaid Services. AACC also contacted House and Senate staff and legislators to discuss the harmonization of clinical laboratory test results. The Accompanying Language to the Consolidated and Further Continuing Appropriations Act of 2015 included a recommendation under the Centers for Disease Control Prevention Environmental Health section that encourages CDC to work with the private sector in promoting harmonization. AACC mentioned its intent to develop and circulate a legislative proposal to satisfy that recommendation. AACC also expressed its support for federal efforts to advance personalized medicine with House, Senate and White House personnel.	Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE		40000	0	0	2015-07-06T16:24:44.520000-04:00